Overview

Spun out from Caliper Technologies Corp. in September 2001, Amphora Discovery Corp. is focused on creating and commercializing a database of chemical genomics information for use in preclinical drug discovery to accelerate target validation and lead identification.

Amphora is building its chemical genomics database with an exclusive license to use Caliper s LabChip high-throughput screening systems, designed to accelerate the identification, optimization and development of clinical candidates.

Amphora raised $25 million in venture capital funding and has entered into agreements for another $10 million investment.